The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


Dollar Gains Slightly as U.S.-Iran Tensions Keep Forex Markets on Edge
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
Oil Prices Jump After New U.S. Strikes on Iran Raise Supply Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
SQM Q1 Profit More Than Doubles as Lithium Prices Surge
Tokyo Inflation Cools in May, Supporting BOJ’s Cautious Rate Hike Path
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Wall Street Reaches New Record Highs as AI Boom and Iran Ceasefire Hopes Boost Markets
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead 



